Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro de Mingo Pulido

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Immunology|June 16, 2015
A new mouse strain for the analysis of invariant NKT cell functionShilpi Chandra, Meng Zhao, Alison Budelsky, et al.
Cancers|March 11, 2023
NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor ModelsBenson Chellakkan Selvanesan, Alvaro de Mingo Pulido, Sheelu Varghese, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Microbiome modulates immunotherapy response in cutaneous squamous cell carcinomaAnita Y Voigt, Andrew Walter, Timothy Young, et al.
Experimental Dermatology|June 23, 2023
Microbiome modulates immunotherapy response in cutaneous squamous cell carcinomaAnita Y Voigt, Andrew Walter, Timothy H Young, et al.
Cancer Research|April 27, 2025
Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK InhibitorsJyoti Srivastava, Vipin K Yadav, Rachel V Jimenez, et al.
The Journal of Investigative Dermatology|December 10, 2021
miR-181a Promotes Multiple Protumorigenic Functions by Targeting TGFβR3Vida Chitsazzadeh, Tran N Nguyen, Alvaro de Mingo Pulido, et al.
Immunity|April 16, 2020
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING SignalingEslam Mohamed, Rosa A Sierra, Jimena Trillo-Tinoco, et al.
Cancer Discovery|March 5, 2022
Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell LymphomaXiaofei Song, Shiun Chang, Lucia Seminario-Vidal, et al.
Cancer Discovery|July 26, 2024
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy EfficacyZachary Z Reinstein, Yue Zhang, Oscar E Ospina, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Immunology|June 16, 2015
A new mouse strain for the analysis of invariant NKT cell functionShilpi Chandra, Meng Zhao, Alison Budelsky, et al.
Cancers|March 11, 2023
NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor ModelsBenson Chellakkan Selvanesan, Alvaro de Mingo Pulido, Sheelu Varghese, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Microbiome modulates immunotherapy response in cutaneous squamous cell carcinomaAnita Y Voigt, Andrew Walter, Timothy Young, et al.
Experimental Dermatology|June 23, 2023
Microbiome modulates immunotherapy response in cutaneous squamous cell carcinomaAnita Y Voigt, Andrew Walter, Timothy H Young, et al.
Cancer Research|April 27, 2025
Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK InhibitorsJyoti Srivastava, Vipin K Yadav, Rachel V Jimenez, et al.
The Journal of Investigative Dermatology|December 10, 2021
miR-181a Promotes Multiple Protumorigenic Functions by Targeting TGFβR3Vida Chitsazzadeh, Tran N Nguyen, Alvaro de Mingo Pulido, et al.
Immunity|April 16, 2020
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING SignalingEslam Mohamed, Rosa A Sierra, Jimena Trillo-Tinoco, et al.
Cancer Discovery|March 5, 2022
Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell LymphomaXiaofei Song, Shiun Chang, Lucia Seminario-Vidal, et al.
Cancer Discovery|July 26, 2024
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy EfficacyZachary Z Reinstein, Yue Zhang, Oscar E Ospina, et al.
Pageof 1